Baxter International has issued a voluntary recall of one lot of cefazolin in dextrose injection after a report that cardboard was found in an IV infusion bag.
The recalled lot is for LD175708 with a February 2027 expiration date. The batch was distributed nationwide in the U.S. between March and June of 2025, the company said in a letter posted to the FDA website this week.
The solution is primarily used to treat or prevent bacterial infections during surgery.
Any use of a contaminated product could lead to a “reasonable probability” of blocking pulmonary and other blood vessels, the company said, adding that the particles could also trigger systemic activation of the immune system, organ dysfunction and a breakdown of blood cells.
Baxter said that, as of July 24, it hadn't received any reports of adverse effects related to the recall.
The voluntary recall comes almost a year to the day after the company and the regulatory agency began efforts warning healthcare providers to change out Baxter’s Novu IQ infusion pump IV administration set or switch to another pump in the wake of reports of 79 serious injuries and two deaths due to a software glitch.
The pump had a problem of either delivering too much or too little medication and other fluids.
By August of last year, issues with the pump and softer-than-expected demand for IV fluids following damage caused to Baxter’s North Carolina manufacturing plant by Hurricane Helene led to the company trimming its revenue projections for the year, sending its stock down by more than 20%.